Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 3
2019 3
2020 10
2021 7
2022 8
2023 9
2024 10
2025 10
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.
Petrella F, Rizzo S, Attili I, Passaro A, Zilli T, Martucci F, Bonomo L, Del Grande F, Casiraghi M, De Marinis F, Spaggiari L. Petrella F, et al. Among authors: attili i. Curr Oncol. 2023 Mar 7;30(3):3160-3175. doi: 10.3390/curroncol30030239. Curr Oncol. 2023. PMID: 36975452 Free PMC article. Review.
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting.
de Marinis F, Ardizzoni A, Attili I, Bonanno L, Bria E, Cortinovis DL, Margaritora S, Mazzoni F, Mercadante E, Morabito A, Petrella F, Rea F, Salvi R, Solli P, Spaggiari L, Voltolini L, Gridelli C. de Marinis F, et al. Among authors: attili i. Curr Oncol. 2025 Feb 14;32(2):110. doi: 10.3390/curroncol32020110. Curr Oncol. 2025. PMID: 39996910 Free PMC article. Review.
Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials.
Attili I, Fuorivia V, Spitaleri G, Corvaja C, Trillo Aliaga P, Del Signore E, Asnaghi R, Carnevale Schianca A, Passaro A, de Marinis F. Attili I, et al. Cancers (Basel). 2024 Jul 4;16(13):2457. doi: 10.3390/cancers16132457. Cancers (Basel). 2024. PMID: 39001519 Free PMC article. Review.
Understanding EGFR heterogeneity in lung cancer.
Passaro A, Malapelle U, Del Re M, Attili I, Russo A, Guerini-Rocco E, Fumagalli C, Pisapia P, Pepe F, De Luca C, Cucchiara F, Troncone G, Danesi R, Spaggiari L, De Marinis F, Rolfo C. Passaro A, et al. Among authors: attili i. ESMO Open. 2020 Oct;5(5):e000919. doi: 10.1136/esmoopen-2020-000919. ESMO Open. 2020. PMID: 33067323 Free PMC article. Review.
63 results